Table 3.
Sample | α1 | α2 | α3 | τ1 (ns) | τ2 (ns) | τ3 (ns) | 〈τ〉∗ (ns) |
---|---|---|---|---|---|---|---|
UDP-MurNAc-pentapeptide-DNS | 0.22 ± 0.02 | 0.03 ± 0.02 | 0.75 ± 0.02 | 0.20 ± 0.06 | 1.38 ± 0.53 | 3.58 ± 0.12 | 2.77 ± 0.06 |
DNS-lipid I | 0.19 ± 0.01 | 0.06 ± 0.01 | 0.75 ± 0.02 | 0.92 ± 0.14 | 4.23 ± 0.31 | 14.28± 0.09 | 11.16 ± 0.15 |
DNS-lipid I/clausin | 0.21 ± 0.02 | 0.14 ± 0.01 | 0.65 ± 0.02 | 0.65 ± 0.10 | 2.45 ± 0.47 | 11.88 ± 0.24 | 8.20 ± 0.05 |
DNS-lipid II | 0.20 ± 0.01 | 0.08 ± 0.01 | 0.72 ± 0.01 | 0.66 ± 0.15 | 3.33 ± 0.38 | 14.32 ± 0.03 | 10.69 ± 0.28 |
DNS-lipid II/clausin | 0.23 ± 0.01 | 0.12 ± 0.03 | 0.65 ± 0.03 | 0.81 ± 0.11 | 3.19 ± 1.05 | 11.98 ± 0.25 | 8.36 ± 0.25 |
Microcuvettes of 140 μL were used. Clausin concentration, 130 μM; DPC, 1%; excitation, 375 nm; emission, 525 nm + Schott KV418 cutoff filter.
Amplitude-averaged lifetime was defined as .